Discover trends, market shifts, and competitive outlooks for the convalescent plasma therapy industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
What is the Anticipated CAGR of the Convalescent Plasma Therapy Market, and What Factors Will Drive It?
In the past few years, the market size for convalescent plasma therapy has seen a significant increase. The market is projected to expand from $0.05 billion in 2024 to $0.06 billion in 2025, with a compound annual growth rate (CAGR) of 11.4%. The substantial growth during the historic period can be tied to factors such as pandemics and outbreaks of infectious diseases, research in immunotherapy, emergency use authorization (eua), the availability of patients, as well as awareness among clinicians and the public.
Anticipated to experience a swift development in the ensuing years, the convalescent plasma therapy market size is predicted to reach $0.09 billion by 2029, with a compound annual growth rate (CAGR) of 13.7%. This surge during the projection period can be linked to the evolution of pathogens, the progression of immunotherapies, regulatory systems, world readiness, and public health programs. Key trends during this forecast period comprise standardized gathering and handling, specific plasma components, tailor-made treatments, telehealth and distance monitoring, and investigation into enduring effects.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3233&type=smp
What External and Internal Drivers Are Contributing to the Growth of the Convalescent Plasma Therapy Market?
The market expansion in the forecast period can be bolstered by the superior effectiveness and safety exhibited during the clinical trials for Convalescent Plasma Therapy (CPT) in treating COVID-19 patients. Previously, the treatment method had attracted attention during historic incidents of other infectious diseases like SARS-1, Middle East Respiratory Syndrome (MERS), and 2009 H1N1. In June 2022, a study executed by the Houston Methodist Hospital to analyze the safety and effectiveness of the convalescent plasma therapy for COVID-19, confirmed that it’s a safe treatment option without any recorded adverse effects and has an efficiency rate of 76%. Another study conveyed in May 2020, featured in the Journal of Medical Virology, claimed that the use of convalescent plasma therapy can see a decline in the fatality rates in critically ill patients, improvement in clinical symptoms can be witnessed and there will be escalation in neutralizing antibody titers along with the disappearance of SARS-CoV-2 RNA. The assured safety and effectiveness of convalescent plasma therapy in managing COVID-19 will fuel the growth of the global convalescent plasma therapy market.
What Segment Types Define the Convalescent Plasma Therapy Market Structure?
The convalescent plasma therapy market covered in this report is segmented –
1) By Antibody type: IgM, IgG, IgA
2) By Application: Prophylaxis, Treatment
3) By End-Users: Hospitals And Clinics, Laboratories And Research institutes
Subsegments:
1) By IgM: Early-Stage Infection Plasma, Acute Phase Plasma, Other IgM-Based Plasma Products
2) By IgG: High Titer IgG Plasma, Standard IgG Plasma, Other IgG-Based Plasma Products
3) By IgA: Plasma Rich In IgA, Specific IgA Antibody Plasma, Other IgA-Based Plasma Products
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=3233&type=smp
Which Geographic Areas Hold the Strongest Growth Potential in the Convalescent Plasma Therapy Market?
North America was the largest region in the convalescent plasma therapy market in 2023. Western Europe was the second largest region in the convalescent plasma therapy market. The regions covered in the convalescent plasma therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Long-Term Trends Are Transforming the Competitive Landscape of the Convalescent Plasma Therapy Market?
The evolution of immunotherapy based on antibodies as a possible treatment solution for COVID-19 provides a potential growth avenue for the convalescent plasma therapy market. This therapy uses antibodies generated against the coronavirus from a donor to enhance the recipient’s immunity. Companies are now launching trials and forming collaborations, and making investments in antibody-based therapy specifically for COVID-19. Regeneron Pharmaceuticals Inc., a biotech firm based in the U.S., joined forces with the Biomedical Advanced Research and Development Authority (BARDA) in August 2023, to support the clinical progression, manufacturing, and licensing processes of the future-generation COVID-19 monoclonal antibody treatment aimed at preventing SARS-CoV-2 infection. This partnership is under the framework of Project NextGen, a U.S. Department of Health and Human Services (HHS) initiative developing a series of modern COVID-19 vaccines and treatments. In line with the project’s framework, Regeneron is set to independently put forward an antibody candidate, which will be evaluated by both BARDA and Regeneron for further research, manufacturing, and regulatory tasks. As convalescent plasma therapy employs antibodies, the increasing focus on antibody-based COVID-19 therapy boosts the market prospect.
View the full report here:
https://www.thebusinessresearchcompany.com/report/convalescent-plasma-therapy-global-market-report
What Is the Definition of the Convalescent Plasma Therapy Market?
Convalescent plasma is plasma that has been collected from people who have recovered or are convalescing and contains antibodies against the infection-causing microorganism. It is used for the treatment of patients infected by the respective pathogen.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3233
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
